Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PeptaNova GmbH is a specialized biotechnology company and life science supplier based in Sandhausen, Germany. Founded in 2000, the company serves as the primary European distributor for the Peptide Institute, Inc. of Osaka, Japan, providing researchers with high-purity peptides, biochemicals, and enzyme inhibitors. Their extensive product catalog supports studies in neurobiology, cardiovascular research, and endocrinology, featuring well-known reagents like amyloid-beta peptides and endothelin. In addition to catalog items, PeptaNova offers custom peptide synthesis services and specialized reagents for assay development. The company is a key resource for academic and industrial researchers seeking reliable synthetic peptides and pharmacological tools for drug discovery and biochemical analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PeptaNova.